Immuno-metabolic interfaces in cardiac disease and failure

Cardiovasc Res. 2022 Jan 7;118(1):37-52. doi: 10.1093/cvr/cvab036.

Abstract

The interplay between the cardiovascular system, metabolism, and inflammation plays a central role in the pathophysiology of a wide spectrum of cardiovascular diseases, including heart failure. Here, we provide an overview of the fundamental aspects of the interrelation between inflammation and metabolism, ranging from the role of metabolism in immune cell function to the processes how inflammation modulates systemic and cardiac metabolism. Furthermore, we discuss how disruption of this immuno-metabolic interface is involved in the development and progression of cardiovascular disease, with a special focus on heart failure. Finally, we present new technologies and therapeutic approaches that have recently emerged and hold promise for the future of cardiovascular medicine.

Keywords: Cardiac disease; Heart failure; Inflammation; Metabolism.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / therapeutic use
  • Energy Metabolism* / drug effects
  • Heart / drug effects
  • Heart / physiopathology*
  • Heart Failure / drug therapy
  • Heart Failure / immunology
  • Heart Failure / metabolism*
  • Heart Failure / physiopathology
  • Humans
  • Immune System / drug effects
  • Immune System / immunology
  • Immune System / metabolism*
  • Immune System / physiopathology
  • Inflammation / drug therapy
  • Inflammation / immunology
  • Inflammation / metabolism*
  • Inflammation / physiopathology
  • Inflammation Mediators
  • Myocardium / immunology
  • Myocardium / metabolism*
  • Signal Transduction

Substances

  • Anti-Inflammatory Agents
  • Inflammation Mediators